AmoyDx will be attending the 2023 AACR Annual Meeting in Florida
Date：2023-03-24Source: AmoyDx
The 2023 AACR (American Association for Cancer Research) Annual Meeting kicks off on April 14 in Florida!
Visit us at booth 1220 to see how we're helping healthcare professionals optimize cancer patients' treatment selections by providing accurate, fast genetic insights, and to learn more about our companion diagnostic solutions.
Recommend
Highlights of China International Import Expo (CIIE) 2023 - Amoy Diagnostics Announced Multiple Collaborations with AstraZeneca and Pfizer
13 /11
AmoyDx® Microsatellite Instability (MSI) Detection Kit Received NMPA Approval for Pan-Tumor Immunotherapy Companion Diagnostics
03 /11
AmoyDx Collaborates with AstraZeneca to Develop a HER2 Companion Diagnostic for Lung Cancer in China
15 /08
AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC
27 /03
AmoyDx will be attending the 2023 AACR Annual Meeting in Florida
24 /03